Journal
ONCOGENE
Volume 34, Issue 47, Pages 5771-5780Publisher
SPRINGERNATURE
DOI: 10.1038/onc.2015.85
Keywords
-
Funding
- Uniting Against Lung Cancer
- National Cancer Institute [1R01CA166376, 1R21CA170537, 1R01CA191489]
Ask authors/readers for more resources
Lung cancer encompasses a heterogeneous group of malignancies. Here we discuss how the remarkable diversity of major lung cancer subtypes is manifested in their transforming cell of origin, oncogenic dependencies, phenotypic plasticity, metastatic competence and response to therapy. More specifically, we review the increasing evidence that links this biological heterogeneity to the deregulation of cell lineage-specific pathways and the transcription factors that ultimately control them. As determinants of pulmonary epithelial differentiation, these poorly characterized transcriptional networks may underlie the etiology and biological progression of distinct lung cancers, while providing insight into innovative therapeutic strategies.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available